These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 17976158

  • 1. Clinicopathological study of nonalcoholic fatty liver disease in Japan: the risk factors for fibrosis.
    Miyaaki H, Ichikawa T, Nakao K, Yatsuhashi H, Furukawa R, Ohba K, Omagari K, Kusumoto Y, Yanagi K, Inoue O, Kinoshita N, Ishibashi H, Yano M, Eguchi K.
    Liver Int; 2008 Apr; 28(4):519-24. PubMed ID: 17976158
    [Abstract] [Full Text] [Related]

  • 2. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome.
    Sanyal AJ, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Stravitz RT, Mills AS.
    Am J Gastroenterol; 2003 Sep; 98(9):2064-71. PubMed ID: 14499789
    [Abstract] [Full Text] [Related]

  • 3. Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease.
    Kaneda H, Hashimoto E, Yatsuji S, Tokushige K, Shiratori K.
    J Gastroenterol Hepatol; 2006 Sep; 21(9):1459-65. PubMed ID: 16911693
    [Abstract] [Full Text] [Related]

  • 4. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease.
    Mathurin P, Hollebecque A, Arnalsteen L, Buob D, Leteurtre E, Caiazzo R, Pigeyre M, Verkindt H, Dharancy S, Louvet A, Romon M, Pattou F.
    Gastroenterology; 2009 Aug; 137(2):532-40. PubMed ID: 19409898
    [Abstract] [Full Text] [Related]

  • 5. Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease.
    Hossain N, Afendy A, Stepanova M, Nader F, Srishord M, Rafiq N, Goodman Z, Younossi Z.
    Clin Gastroenterol Hepatol; 2009 Nov; 7(11):1224-9, 1229.e1-2. PubMed ID: 19559819
    [Abstract] [Full Text] [Related]

  • 6. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values.
    Mofrad P, Contos MJ, Haque M, Sargeant C, Fisher RA, Luketic VA, Sterling RK, Shiffman ML, Stravitz RT, Sanyal AJ.
    Hepatology; 2003 Jun; 37(6):1286-92. PubMed ID: 12774006
    [Abstract] [Full Text] [Related]

  • 7. A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease.
    Zelber-Sagi S, Kessler A, Brazowsky E, Webb M, Lurie Y, Santo M, Leshno M, Blendis L, Halpern Z, Oren R.
    Clin Gastroenterol Hepatol; 2006 May; 4(5):639-44. PubMed ID: 16630771
    [Abstract] [Full Text] [Related]

  • 8. Nonalcoholic fatty liver disease. Correlation with histology and viral hepatitis.
    Akyol G, Erdem O, Yilmaz G.
    Saudi Med J; 2005 Dec; 26(12):1904-10. PubMed ID: 16380770
    [Abstract] [Full Text] [Related]

  • 9. Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD.
    Savvidou S, Hytiroglou P, Orfanou-Koumerkeridou H, Panderis A, Frantzoulis P, Goulis J.
    J Clin Gastroenterol; 2009 Sep; 43(8):765-72. PubMed ID: 19525862
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study.
    Harrison SA, Torgerson S, Hayashi PH.
    Am J Gastroenterol; 2003 Sep; 98(9):2042-7. PubMed ID: 14499785
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C.
    Saadoun D, Asselah T, Resche-Rigon M, Charlotte F, Bedossa P, Valla D, Piette JC, Marcellin P, Cacoub P.
    Hepatology; 2006 Jun; 43(6):1337-45. PubMed ID: 16729318
    [Abstract] [Full Text] [Related]

  • 14. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H, Gonzalez JL, Márquez-Ramirez MD, Flores-Hernandez M, Rodríguez-Morán M, Guerrero-Romero F.
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease.
    Schwimmer JB, Deutsch R, Rauch JB, Behling C, Newbury R, Lavine JE.
    J Pediatr; 2003 Oct; 143(4):500-5. PubMed ID: 14571229
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).
    Yoneda M, Yoneda M, Mawatari H, Fujita K, Endo H, Iida H, Nozaki Y, Yonemitsu K, Higurashi T, Takahashi H, Kobayashi N, Kirikoshi H, Abe Y, Inamori M, Kubota K, Saito S, Tamano M, Hiraishi H, Maeyama S, Yamaguchi N, Togo S, Nakajima A.
    Dig Liver Dis; 2008 May; 40(5):371-8. PubMed ID: 18083083
    [Abstract] [Full Text] [Related]

  • 20. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies.
    Adams LA, Sanderson S, Lindor KD, Angulo P.
    J Hepatol; 2005 Jan; 42(1):132-8. PubMed ID: 15629518
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.